top of page
Home
shutterstock_1044093637.png

eGERD

A novel device for a billion people suffering from Reflux, Heartburn & Regurgitation

GERD

Gastro Esophageal Reflux Disease [GERD] is one of the most common digestive disorders, affecting a billion people globally who suffer from reflux, heartburn and regurgitation.

GERD main complications are Barrett disease and esophageal cancer.

Data-Driven, Remote & Personalized Treatment

Proprietary smartphone application controls the eGERD device and generates clinical data securely stored on the GerdCare cloud.

Collected data is processed to create personalized and optimized treatment.

Architectura2.png

How It Works

​The eGERD is a digital therapeutic electro-stimulator, generating modulated asymmetrical electrical bursts of pulses synchronized with breathing. Abdominal muscles are contracted in an asymmetrical manner inducing improvement in the functionality of the Lower Esophagel Sphincter [LES] and reducing acid reflux from the stomach to the esophagus.

eGERD platform

A novel, unique, drug-free, non-invasive, user friendly medical platform designed for alleviating symptoms of GERD. ​No preparations are required prior to usage. It is set to immediate use, anytime, anywhere by any GERD patient.

eGERD device
How it Works
eGERD device

eGERD Device

Bluetooth

smartphone.png

WiFi/Cellular

Cloude.png

Proprietary SmartPhone App

Cloud Storage

WiFi/LAN

Desktop.png

Desktop Client

Clinical Results

​Clinical Results

2019 - 2022

Multi Center Pilot Clinical Study,

31 patients

75%

Reduction in

Acid Exposure & DeMeester score

Reduction in

Heartburn & Regurgitation

75%

​within a few days of device use

​within a few days of device use

Reduction in

Acid Exposure & DeMeester score

90%

​within a few days of device use

About Gerd

eGERD benefits

Rapid Symptoms Relief

Drug Free

Non Invasive

Affordable

Self Use

Safe

Stump.png

​Safety and Effectiveness Clinically Proven

eGERD Benefit

Global Market

$4.6B

1 Billion people

affected by GERD

$2.75B

PPI drugs market

USA Market

$1.3B

$24B direct & indirect annual economy burden

67M

Americans diagnosed with GERD

Current solutions

PPI drugs 

  • PPI treatment for GERD is ineffective for up to 40% of patients using the drug.

  • Chronic use of PPI’s reduces stomach acidity levels, impairing nutrient absorption; Other long-term risks include Osteoporosis, Neurological Disorders, Dementia, Kidney disease and Cancer.

 

Surgical procedures [Fundoplication, LINX]

  • Low acceptance rate due to inavsiveness, associated risks and long recovery.

About Us

About Us

GerdCare Medical is a digital therapeutic company developing a unique and novel drug-free solution for treatment of Gastroesophageal Reflux Disease [GERD].  The eGERD is a non-invasive medical device, clinically proven to be safe & effective. The eGERD is a self-use wearable device. It can be used anytime, anywhere.

Meet The Management Team

Dr.-Shimon-Eckhouse.png

Dr. Shimon Eckhouse
Chairman

Prominent serial entrepreneur and investor in companies such as Syneron, Lumenis and Ventor [acquired by Medtronic]

David-Hanuka.png

David Hanuka, MBA
CEO

Entrepreneur, inventor and medical device industry executive, introducing a wide range of medical technologies to market, strategic collaborating and M&A’s.

גיורא.png

Giora Arbel

Co-Founder, VP of R&D

M.Sc. in engineering and Operation Research. 45+ years of R&D management experience in Aeronautics and medical devices, including development of electrical stimulators

WhatsApp Image 2023-05-10 at 16.06.57.jpg

Moti Esh, MD

Co-Founder, CTO

Both a physician and an engineer, Dr. Esh has 40+ years of development and engineering experience in medical devices, including developing electrical stimulators

מאיר אור - תמונה לתג_edited.jpg

Meir Or,  M.Sc.

Product Manager

Experienced R&D team leader in medical device development, with strong multidisciplinary background. B.Sc. and M.Sc. Biomedical Engineering.

Ester-Pri-Or.png

Ester Pri-Or
Clinical Operations Mgr.

A certified nurse with over 15 years of experience managing clinical research in several medical device companies

Contact Us

Thanks for submitting!

3 Hatnufa street, 7th floor, High-tech Park, Yokneam Ilit

Israel, 2069207

 

Dr. M. Esh:

+972-55-9984415

info@Gerd-Care.com

Contact Us

Managment Team

David Hanuka, MBA

CEO

Entrepreneur, inventor and medical device industry executive, introducing a wide range of medical technologies to market, strategic collaborating and M&A’s.

Ester Pri-Or

Clinical Operations Mgr.

A certified nurse with over 15 years of experience managing clinical research in several medical device companies

Moti Esh, MD

Co-Founder, CTO

Both a physician and an engineer, Dr. Esh has 40+ years of development and engineering experience in medical devices, including developing electrical stimulators

Giora Arbel

Co-Founder, VP of R&D

40+ years of R&D management experience in medical devices including managing the development of electrical stimulators

bottom of page